Haematologica publishes articles in the broad field of hematology, reporting on novel findings in basic, clinical and translational research.The scope of the journal is to report novel research results that have an important impact on our understanding of normal hematology or the development of hematological diseases, or are likely to bring important changes to the diagnosis or treatment of hematological diseases.
Haematologica在广泛的血液学领域发表文章，报道基础、临床和转化研究中的新发现，期刊的范围是报道对我们理解正常血液学或血液学疾病的发展有重要影响，或可能给血液学疾病的诊断或治疗带来重要变化的新研究结果。
Clonal hematopoiesis and risk of acute myeloid leukemia
来源期刊：HaematologicaDOI：10.3324/haematol.2018.215269
Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial
来源期刊：HaematologicaDOI：10.3324/haematol.2019.223966
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia
来源期刊：HaematologicaDOI：10.3324/haematol.2019.219550
Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort
来源期刊：HaematologicaDOI：10.3324/haematol.2018.198820
PIEZO1 activation delays erythroid differentiation of normal and hereditary xerocytosis-derived human progenitor cells
来源期刊：HaematologicaDOI：10.3324/haematol.2019.218503
Updates on the hematologic tumor microenvironment and its therapeutic targeting
来源期刊：HaematologicaDOI：10.3324/haematol.2018.195396
How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia?
来源期刊：HaematologicaDOI：10.3324/haematol.2018.208454
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia
来源期刊：HaematologicaDOI：10.3324/haematol.2018.205930
Disruption of the MBD2-NuRD complex but not MBD3-NuRD induces high level HbF expression in human adult erythroid cells
来源期刊：HaematologicaDOI：10.3324/haematol.2018.210963
Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study
来源期刊：HaematologicaDOI：10.3324/haematol.2019.235648
CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies
来源期刊：HaematologicaDOI：10.3324/haematol.2018.197152
Chimeric antigen receptor T-cell therapy for multiple myeloma: a consensus statement from The European Myeloma Network
来源期刊：HaematologicaDOI：10.3324/haematol.2019.224204
High activation of STAT5A drives peripheral T-cell lymphoma and leukemia
来源期刊：HaematologicaDOI：10.3324/haematol.2019.216986
Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the JAK2V617F mutation
来源期刊：HaematologicaDOI：10.3324/haematol.2018.208082
Use of immunosuppressive therapy for management of myelodysplastic syndromes: a systematic review and meta-analysis
来源期刊：HaematologicaDOI：10.3324/haematol.2019.219345
NIPBL: a new player in myeloid cell differentiation
来源期刊：HaematologicaDOI：10.3324/haematol.2018.200899
Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma.
来源期刊：HaematologicaDOI：10.3324/haematol.2019.227579
Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract
来源期刊：HaematologicaDOI：10.3324/haematol.2019.230961
Recurrent stroke: the role of thrombophilia in a large international pediatric stroke population
来源期刊：HaematologicaDOI：10.3324/haematol.2018.211433
Bleeding disorders in adolescents with heavy menstrual bleeding in a multicenter prospective US cohort
来源期刊：HaematologicaDOI：10.3324/haematol.2019.225656
New thiazolidinones reduce iron overload in mouse models of hereditary hemochromatosis and β-thalassemia
来源期刊：HaematologicaDOI：10.3324/haematol.2018.209874
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study.
来源期刊：HaematologicaDOI：10.3324/haematol.2019.227892
Acquisition of the recurrent Gly101Val mutation in BCL2 confers resistance to venetoclax in patients with progressive chronic lymphocytic leukemia (Comment to Tausch et al.)
来源期刊：HaematologicaDOI：10.3324/haematol.2019.232835
Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk
来源期刊：HaematologicaDOI：10.3324/haematol.2019.236588
Long-term follow up after third-party viral-specific cytotoxic lymphocytes for immunosuppression- and Epstein-Barr virus-associated lymphoproliferative disease
来源期刊：HaematologicaDOI：10.3324/haematol.2018.207548
Dynamic prediction of bleeding risk in thrombocytopenic preterm neonates
来源期刊：HaematologicaDOI：10.3324/haematol.2018.208595
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial
来源期刊：HaematologicaDOI：10.3324/haematol.2018.209932
Precision tyrosine kinase inhibitor dosing in chronic myeloid leukemia?
来源期刊：HaematologicaDOI：10.3324/haematol.2018.214445
Shear rate gradients promote a bi-phasic thrombus formation on weak adhesive proteins, such as fibrinogen in a VWF-dependent manner.
来源期刊：HaematologicaDOI：10.3324/haematol.2019.235754
Leukemia cells remodel marrow adipocytes via TRPV4-dependent lipolysis.
来源期刊：HaematologicaDOI：10.3324/haematol.2019.225763
Leprosy drug clofazimine activates peroxisome proliferator-activated receptor-γ and synergizes with imatinib to inhibit chronic myeloid leukemia cells
来源期刊：HaematologicaDOI：10.3324/haematol.2018.194910
Hyperactive GPIb-von Willebrand factor interaction as cause of thrombocytopenia: altered platelet formation versus clearance
来源期刊：HaematologicaDOI：10.3324/haematol.2019.219832
Coactosin-like 1 integrates signaling critical for shear-dependent thrombus formation in mouse platelets
来源期刊：HaematologicaDOI：10.3324/haematol.2019.225516
Recognition of hemophagocytic lymphohistiocytosis in sickle cell vaso-occlusive crises is a potentially lifesaving diagnosis
来源期刊：HaematologicaDOI：10.3324/haematol.2018.206458
Standing at odds: mutated RAS and hematopoietic stem cells
来源期刊：HaematologicaDOI：10.3324/haematol.2019.230029
CD27, CD201, FLT3, CD48, and CD150 cell surface staining identifies long-term mouse hematopoietic stem cells in immunodeficient non-obese diabetic severe combined immune deficient-derived strains
来源期刊：HaematologicaDOI：10.3324/haematol.2018.212910
Co-inheritance of a-thalassemia dramatically decreases the risk of acute splenic sequestration in a large cohort of newborns with hemoglobin SC
来源期刊：HaematologicaDOI：10.3324/haematol.2018.209221
Humanized zebrafish enhance human hematopoietic stem cell survival and promote acute myeloid leukemia clonal diversity
来源期刊：HaematologicaDOI：10.3324/haematol.2019.223040
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.
来源期刊：HaematologicaDOI：10.3324/haematol.2019.238162
The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs
来源期刊：HaematologicaDOI：10.3324/haematol.2019.224956
Are we ready to use precision medicine in chronic myeloid leukemia practice?
来源期刊：HaematologicaDOI：10.3324/haematol.2019.231753
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies
来源期刊：HaematologicaDOI：10.3324/haematol.2018.215210
Ubiquitination is not omnipresent in myeloid leukemia
来源期刊：HaematologicaDOI：10.3324/haematol.2019.224162
Murine tissue factor disulfide mutation causes a bleeding phenotype with sex specific organ pathology and lethality
来源期刊：HaematologicaDOI：10.3324/haematol.2019.218818
Repurposing pyridoxamine for therapeutic intervention of intravascular cell-cell interactions in mouse models of sickle cell disease
来源期刊：HaematologicaDOI：10.3324/haematol.2019.226720
The novel L-nucleoside analogue, 5-Fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia.
来源期刊：HaematologicaDOI：10.3324/haematol.2019.226795
DNA damage on the DOCK in FLT3-ITD-driven acute myeloid leukemia
来源期刊：HaematologicaDOI：10.3324/haematol.2019.231340
A tale of two genes: a new connection between NIPBL and NPM1 in acute myeloid leukemia
来源期刊：HaematologicaDOI：10.3324/haematol.2019.218867
Quantification of minimal disseminated disease by quantitative polymerase chain reaction and digital polymerase chain reaction for NPM-ALK as a prognostic factor in children with anaplastic large cell lymphoma
来源期刊：HaematologicaDOI：10.3324/haematol.2019.232314
IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study
来源期刊：HaematologicaDOI：10.3324/haematol.2019.220194
